Insider · CIK 0001627810

Donegan Michael C

Reports to the SEC for 1 company · BOCA RATON, FL

sec.gov

Transactions

Companies

Filings

CIK

0001627810

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-04-12	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+50K sh	—	—	61,853
2023-04-12	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−50K sh	—	—	0
2023-02-21	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+50K sh	—	—	50,000
2023-01-27	TXMDTherapeuticsMD, Inc.S Sale	Prin. Fin. and Acctg. Officer	SSale	−49 sh	$5.09	−$249.41	11,853
2023-01-26	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+2,400 sh	—	—	10,010
2023-01-26	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+2,400 sh	—	—	12,410
2023-01-26	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+1,140 sh	—	—	13,550
2023-01-26	TXMDTherapeuticsMD, Inc.S Sale	Prin. Fin. and Acctg. Officer	SSale	−1,648 sh	$5.08	−$8,371.181	11,902
2023-01-26	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−2,400 sh	—	—	0
2023-01-26	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−2,400 sh	—	—	0
2023-01-26	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−1,140 sh	—	—	0
2023-01-24	TXMDTherapeuticsMD, Inc.S Sale	Prin. Fin. and Acctg. Officer	SSale	−7 sh	$5.31	−$37.171	7,610
2023-01-23	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+380 sh	—	—	4,934
2023-01-23	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+1,066 sh	—	—	6,000
2023-01-23	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+519 sh	—	—	6,519
2023-01-23	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+2,400 sh	—	—	8,919
2023-01-23	TXMDTherapeuticsMD, Inc.S Sale	Prin. Fin. and Acctg. Officer	SSale	−1,302 sh	$5.34	−$6,950.467	7,617
2023-01-23	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−380 sh	—	—	0
2023-01-23	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−1,066 sh	—	—	0
2023-01-23	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−519 sh	—	—	0
2023-01-23	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−2,400 sh	—	—	0
2022-12-06	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+2,300 sh	—	—	4,288
2022-12-06	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+380 sh	—	—	4,668
2022-12-06	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+534 sh	—	—	5,202
2022-12-06	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+262 sh	—	—	5,464
2022-12-06	TXMDTherapeuticsMD, Inc.S Sale	Prin. Fin. and Acctg. Officer	SSale	−910 sh	$4.78	−$4,345.25	4,554
2022-12-06	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−2,300 sh	—	—	0
2022-12-06	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−380 sh	—	—	380
2022-12-06	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−534 sh	—	—	1,066
2022-12-06	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−262 sh	—	—	519
2022-03-31	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+120K sh	—	—	120,000
2022-03-23	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+120K sh	—	—	120,000
2021-11-30	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+115K sh	—	—	129,158
2021-11-30	TXMDTherapeuticsMD, Inc.S Sale	Prin. Fin. and Acctg. Officer	SSale	−29.8K sh	$0.54	−$15.9K	99,368
2021-11-30	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−115K sh	—	—	115,000
2021-09-29	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+39K sh	—	—	38,954
2021-09-29	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)J Other	Prin. Fin. and Acctg. Officer	JOther	−50K sh	—	—	0
2021-09-29	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)J Other	Prin. Fin. and Acctg. Officer	JOther	−100K sh	—	—	0
2021-09-29	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)J Other	Prin. Fin. and Acctg. Officer	JOther	−40K sh	—	—	0
2021-09-29	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)J Other	Prin. Fin. and Acctg. Officer	JOther	−100K sh	—	—	0
2021-07-01	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+160K sh	—	—	160,000
2021-07-01	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+80K sh	—	—	80,000
2021-05-11	TXMDTherapeuticsMD, Inc.S Sale	Prin. Fin. and Acctg. Officer	SSale	−4,842 sh	$1.04	−$5,035.68	14,158
2021-05-10	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	+19K sh	—	—	19,000
2021-05-10	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Prin. Fin. and Acctg. Officer	MExercise/Conversion	−19K sh	—	—	38,000
2020-11-24	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+230K sh	—	—	230,000
2020-03-30	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+57K sh	—	—	57,000
2020-03-30	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Prin. Fin. and Acctg. Officer	AAward	+57K sh	—	—	57,000
2019-08-28	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Prin. Fin. and Acctg. Officer	AAward	+120K sh	—	—	120,000
2018-03-15	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Prin. Fin. and Acctg. Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Apr 144
Donegan Michael C0001209191-23-024386
SEC(opens sec.gov)
Feb 234
Donegan Michael C0001209191-23-012271
SEC(opens sec.gov)
Jan 304
Donegan Michael C0001209191-23-005554
SEC(opens sec.gov)
Jan 254
Donegan Michael C0001209191-23-004871
SEC(opens sec.gov)

Companies

TherapeuticsMD, Inc.Prin. Fin. and Acctg. OfficerTXMD

Address

6800 BROKEN SOUND PARKWAY NW THIRD FLOOR

BOCA RATON, FL, 33487-3507